⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →

India Glycols Limited (INDIAGLYCO) — Corporate Action | 31 July 2026(2 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings
1 Corporate Action 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Akshay Bansal appointed as Additional Director and KMP at Ennature Bio Pharma.
🔄 What Changed
Senior Managerial Personnel transferred to subsidiary; new appointment as KMP.
🔮 What's Next
Appointment term of 5 years until July 30, 2031.
💡 Investor Takeaway
This leadership move strengthens Ennature Bio Pharma's management continuity.

India Glycols announced the transfer of Akshay Bansal, Head of Sales & Marketing for Ennature Biopharma, to become an Additional Director and Key Managerial Personnel at Ennature Bio Pharma Limited, effective July 31, 2026, following regulatory filings and shareholder approval requirements.

2 Corporate Action 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Cessation of Akshay Bansal as Senior Managerial Personnel and appointment as KMP at Ennature Bio Pharma.
🔄 What Changed
Transfer of Akshay Bansal from India Glycols to Ennature Bio Pharma as Senior Managerial Personnel; appointment as Additional Director and KMP at Ennature Bio Pharma.
💡 Investor Takeaway
The leadership change at Ennature Bio Pharma may affect its strategic direction and governance, potentially influencing India Glycols' subsidiary dynamics and shareholder value.

India Glycols announced the cessation of Akshay Bansal as a Senior Managerial Personnel effective July 31, 2026, following his transfer to Ennature Bio Pharma. The filing details regulatory compliance with SEBI Listing Regulations and references Observation Letters from NSE and BSE concerning the Scheme of Arrangement. It also confirms Ennature Bio Pharma's appointment of Bansal as Additional Director and Key Managerial Personnel effective July 31, 2026, with a five-year term until July 30, 2031.

⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →
📊 Stock Analysis — INDIAGLYCO ✨ Ask AI About This

About India Glycols Limited (INDIAGLYCO)

Fast Moving Consumer Goods · Alcoholic Beverages · Listed on NSE

Market Cap: ₹1,789.28 Cr P/E: 5.4 ROE: 10.8% ROCE: 12.3% Div Yield: 2.81%

View full INDIAGLYCO stock details →

📡 Get AI alerts when INDIAGLYCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDIAGLYCO — Free

💡 Ask AI about this filing

Ask AI Free →

📊 More INDIAGLYCO filings

See all INDIAGLYCO filings →

🔥 Also filed on 31 July 2026

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDIAGLYCO files new disclosures

Track INDIAGLYCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDIAGLYCO — Free

Free account · 2 AI queries/day

⚡ StockFin Pro Go Pro — bigger Radar, no daily limits Upgrade

© 2026 StockFin.ai — AI-powered Indian stock research

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd